Needed to rapidly construct knockout cell lines for multiple targets to validate drug screening
Using our high-throughput CRISPR/Cas9 RNP technology platform, we completed the construction of knockout cell lines for 20 targets within 2 weeks
Successfully validated 3 novel drug targets, saving 6 months in subsequent drug development timeline
"ELEM Biotech's high-throughput gene editing platform has significantly accelerated our drug discovery process. Their professional technical support team has been tremendously helpful."
— Leading Pharmaceutical Company